» Articles » PMID: 12421926

TRAIL/Apo-2 Ligand Induces Primary Plasma Cell Apoptosis

Overview
Journal J Immunol
Date 2002 Nov 8
PMID 12421926
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Apoptosis constitutes the primary mechanism by which noncycling plasma cells are eliminated after the secretion of Ag-specific Abs in a humoral immune response. The underlying mechanism is not known. Here, we demonstrate that the expression of both TRAIL/Apo-2 ligand and the death receptors (DR) DR5 and DR4, but not Fas, are sustained in IL-6-differentiated Ig-secreting human plasma cells as well as primary mouse plasma cells generated in a T-dependent immune response. Plasma cell apoptosis is induced by both endogenous and exogenous TRAIL ex vivo, suggesting that TRAIL-mediated killing may, in part, be plasma cell autonomous. By contrast, resting and activated B cells are resistant to TRAIL killing despite comparable expression of TRAIL and DRs. The preferential killing of plasma cells by TRAIL correlates with decreased expression of CD40 and inactivation of NF-kappaB. These results provide the first evidence that primary plasma cells synthesize TRAIL and are direct targets of TRAIL-mediated apoptosis, which may relate to the inactivation of the NF-kappaB survival pathway.

Citing Articles

Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics.

Kumar V Int Immunopharmacol. 2020; 88:106980.

PMID: 33182073 PMC: 7843151. DOI: 10.1016/j.intimp.2020.106980.


Suppressed humoral immunity is associated with dengue nonstructural protein NS1-elicited anti-death receptor antibody fractions in mice.

Tsai C, Sun D, Su M, Lien T, Chen Y, Lin C Sci Rep. 2020; 10(1):6294.

PMID: 32286343 PMC: 7156414. DOI: 10.1038/s41598-020-62958-0.


The Role of TRAIL/DRs in the Modulation of Immune Cells and Responses.

Sag D, Ayyildiz Z, Gunalp S, Wingender G Cancers (Basel). 2019; 11(10).

PMID: 31574961 PMC: 6826877. DOI: 10.3390/cancers11101469.


Assessing the Functional Relevance of Variants in the () in a Cohort of Patients With Primary Immunodeficiency.

Eskandarian Z, Fliegauf M, Bulashevska A, Proietti M, Hague R, Smulski C Front Immunol. 2019; 10:568.

PMID: 31057532 PMC: 6477086. DOI: 10.3389/fimmu.2019.00568.


Hetero-oligomerization between the TNF receptor superfamily members CD40, Fas and TRAILR2 modulate CD40 signalling.

Smulski C, Decossas M, Chekkat N, Beyrath J, Willen L, Guichard G Cell Death Dis. 2017; 8(2):e2601.

PMID: 28182009 PMC: 5386471. DOI: 10.1038/cddis.2017.22.